Summary. The number of nuclear thyroxine (T4) or triiodothyronine (T3) receptors and the serum values of thyroxine, triiodothyronine, reverse triiodothyronine and TSH were investigated in 13 patients with Type 1 (insulin-dependent) diabetes (group 1), in 10patients with Type2 (non-insulin-dependent) diabetes (group 2) and in age and weight matched non-diabetic subjects. All patients were clinically euthyroid, although serum 1"3 was low and reverse T 3 high in group 1 compared with the non-diabetic subjects. The Type 1 diabetic patients had evidence of poor metabolic control because of weight loss and high glycosylated haemoglobin levels. The maximal specific nuclear binding capacities for T4 (1.8x10-16mol T4/10lxg DNA) and T3 (1.4x10-16mol T3/10 lxg DNA) were increased in group I compared with the normal subjects (T4:1
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Various abnormalities of thyroid function have been described in diabetes mellitus, including the depression of total serum triiodothyronine (T3) and thyroxine (T4) concentrations in untreated patients [1] . However, decreased circulating concentrations of T4 and T3 do not necessarily reflect decreased hormone concentrations at the receptor site. As the magnitude of effect of thyroid hormones is directly correlated with the quantity of iodothyronine bound specifically to cell nuclei in various organs, we have determined the relationship between the concentrations of thyroid hormones in the blood and nuclear T4 and T3 receptor concentration in patients with diabetes mellitus. of glycosylated haemoglobin, suggesting poor metabolic control. On the day of investigation and the two previous days, ketone bodies were present in the urine, although none of the patients was acidotic as judged by serum bicarbonate levels. Group 2 consisted of ten patients with Type 2 diabetes of duration from 1 to 10 years (Table 1) . No patient had a history of thyroid disease. The control groups comprised eight subjects matched with the patients in group 1 and five subjects matched with the patients in group 2 with regard to weight and age (Table 1 ). All the control subjects were without any signs of diabetes or thyroid disease. Blood samples were drawn for the cellular experiments, total serum thyroxine (T4), total serum triiodothyronine (T3), 1"3 uptake ratio, serum reverse triiodothyronine (rT3), serum thyrotropin (TSH), serum thyroglobulin antibodies and blood glycosylated haemoglobin A1 after informed consent. A TRH test was performed in ten patients with diabetes (five with Type 1 and five with Type 2) and 10 control subjects (five in each group).
Materials and Methods

Patients
Two groups of diabetic patients and two groups of non-diabetic subjects were studied. Group I comprised 13 patients with Type 1 diabetes, who were all judged to require insulin on clinical grounds. The duration of their diabetes ranged from 4 weeks to 10 years. At the time of investigation all patients were underweight and had elevated levels
Methods
Commercially available methods were used for the determinations of serum T4 (Clinical Assays Gammacoat 1"4 kit, Travenol Lab., Cambridge, UK), serum T3 (Amerlex T3 RIA kit, Amersham International, Amersham, UK), I"3 uptake (Clinical Assays Gammacoat T3 uptake kit, Travenol Lab., Cambridge, UK), TSH (Normal Human Serum TSH RIA kit, Diagnostic Products Cooperation, Los Angeles, USA), reverse I"3 (Medilab, Copenhagen, Denmark), thyroglobulin antibod- 
Isolation of Mononuclear Cells from Blood
Mononuclear cells were isolated from 100 ml of blood by a modification of the method of B6yum [2] . Blood was diluted with 0.9% NaC1 and centrifuged at 800 g for 15 min in Lymphoprep (NycoMed, Copenhagen, Denmark). The interphase was harvested and washed twice in Hanks solution. This yielded lymphocytes (80%-90%) and monocytes (10%-20%) but no erythrocytes or platelets as judged by light microscopy. Judged by the trypan blue exclusion test, 98% cells were viable after isolation and incubation for 120 rain. The number of cells was determined in a BOrker-Ttirk chamber (Scherf, Marburg, FRG). Results expressed as mean + SD, a p < 0.10 compared with the nondiabetic group. Reference: serum TSH in euthyroid subjects < 3.0 mU/l of 1 ml. The concentration of 12SI-T4 or 125I-T3 varied from 1.5 x 10 -1~ mol/l to 5.0 x 10-9 mol/1. The specific activity of the preparation was 50 lxCi/~tg (Amersham International, Amersham, UK) and the preparation contained < 3% free 125I and < 1% 125I-T3 in the 125I-T4 preparation and < 1% a25I-T2 in the 125I-T3 preparation. No other iodothyronines could be detected by column chromatography. The cells were incubated at 37 ~ for 90 min. The incubation was terminated by cooling the tubes to 3 ~ as previous experiments had demonstrated that binding at 3 ~ was negligible for up to 18 h.
Uptake of 125 I-T4 or 125I-T3 in Mononuclear Cells
Isolation of Nuclei
After incubation, the cells were washed five times in cold Hanks solution and resuspended in 5 ml of cold buffer (0.25 tool sucrose, 1.1. mmol MgCI2 and 20 mol TRIS/I), pH 7.85, containing 0.5% triton x-100. This suspension was homogenized for 30 s in a Potter-Elvehjem homogenizer (Braun, Melsungen, FRG) to enchance the disruption of the cell membrane, and then centrifuged at 1000g for 10min. All procedures were carried out at 0-3 ~ Washing was repeated once with 5 ml buffer. This procedure yielded nuclei that under phase contrast microscopy appeared intact and clean. More than 90% of the cellular DNA was confined to the nuclear fraction. Finally, 1 ml 95% ethanol was added to extract the iodothyronines. The radioactivity in the nuclei and the supernatant was counted in a gamma scintillation counter (Selektronik, Copenhagen, Denmark). DNA was determined by the method of Burton [3] .
Determination of Deiodination and Deiodination Products
Column chromatography was performed on acrylic columns (K 15/30, Pharmacia, Uppsala, Sweden) filled with Sephadex G25 medium (Pharmacia), equlibrated with phosphate buffer (0.02 tool/l) (pHT.4) and NaOH (0.1 tool/l), NaC1 (0.005 mol/1) at a rate of 32 ml/h. Eighteen fractions (5 ml/fraction) were eluted with phosphate buffer and 32 fractions (5ml/fraction) were eluted with NaOH/NaCI. For reference, chromatography was carried out with 125I, 125I-T3,1~5I-3.3'. 5'-T3 and 1251-3.3'-T2. Results expressed as mean + SD, a p < 0.010, b p < 0.05 compared with the respective control groups
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Analysis of Binding and Deiodination
Experimental correction for non-specific binding was accomplished by incubation of duplicate samples, one with radioactive T4 or T3 alone and one with radioactive T4 or T3 plus a 106-fold excess of nonradioactive T4 or T3 added I h previously. Specific binding was determined as total binding minus non-specific binding. Degradation of T4 during incubation was determined by column chromatography and all results concerning T 4 binding characteristics were corrected for non-T4 radioactivity (endogenous T4 to T3 conversion). The method of Scatchard [41 was used to analyze the binding affinity ofT4 and T~ and to estimate the maximal capacity of the high affinity binding sites by means of linear regression analysis. The results of the determinations of maximal specific binding capacity and ka presented, are the means of two separate determinations, the coefficient of variation being < ]2%.
Wilcoxon's non-parametric rank sum test was used for statistical analysis.
Results
Clinical examination of all diabetic patients showed them to be euthyroid. The results of the measurements of the blood hormone levels are shown in Table 1 , and the results of the TRH tests in Table 2 . In all subjects, the levels of thyroglobulin antibodies were normal.
Cellular Experiments
Nuclear uptake of I25I-T4 and 1251-T3 reached a steady state after 90 min incubation. Recovery of the cellular radioactivity during the fractionation procedures was 91.7 ___ 8.0% (mean _+ SD). Deiodination of T4 or T3 during fractionation, extraction and chromatography was negligible, as control experiments showed deiodination of < 2% of the 125I-T4 after 10 h at 37 ~ Results from parallel incubation of cells from the same subject varied < 12%. Control experiments, in which intact cells were incubated with 125I had shown that t25I was not taken up in the cells. The DNA content in the nuclei was 10.7 ___ 3.8 .ttg DNA/106 nuclei (mean + SD).
The results from the cellular experiments (Figs. 1 and 2) revealed an increased number of high affinity binding sites for T4 and T3 in group 1, whereas the binding affinity did not differ from that of the control groups (Table 3) . Neither the number of high affinity binding sites for T4 or T3 (Figs. 3 and 4) nor the binding affinity for the respective hormones in group 2 differed from those of the control group (Table 3) .
The total cellular concentration of both T4 and T3 was identical in all three groups and constant in the tested concentration range (Fig. 5) .
Discussion
The finding of subnormal total T3 levels in both types of diabetic subjects has confirmed the findings of other investigators [L 5, 6] . Apparently, the low serum levels of T3 are due mainly to a reduction in extrathyroidal conversion of T4 to T3 [7] . However, in spite of the low serum levels of T3, both groups were clinically euthyroid, and basal serum levels of TSH were normal.
The change in circulating thyroid hormone concentrations in diabetic patients clearly resembles those seen in caloric deprivation [8] , and recently these alterations in serum thyroid hormone indices occurring in diabetes mellitus have been suggested to be a response to the presence of a prolonged period of catabolism [5] . This observation corresponds well with the status of the patients in group 1, in whom weight loss, increased serum levels of rT3 and the presence of urinary ketone bodies suggested a catabolic state. In contrast, there was no evidence of prolonged catabolism in group 2 as judged by the above parameters. The low serum T3 levels in group 2 corresponded with the serum T3 levels found in the age-matched control subjects suggesting a physiologically lower T3 level in this older group.
The increased number of nuclear T4 and T3 receptors in group 1, as estimated by the maximal specific binding capacity for T4 and T3 in mononuclear blood cells, corresponds with the recent report of an increase of nuclear T 4 and T3 receptor number in starved man [9] . In contrast with the present observation, a clear reduction in hepatic nuclear binding of T3 in streptozotocintreated rats was reported recently [10] . The explanation for this apparent discrepancy might be afforded by differences in the cellular metabolism of thyroid hormones in man and the rat [11] .
The modest increase in the TSH response to TRH injection in group1 corresponds well with the decreased serum level of T3 observed in this group, but might also indicate a decrease of serum T4, as an augmented TSH response to TRH indicates a decrease in serum T4 or T3 below the normal pituitary set point for feedback [12] . However, the normal basal TSH level could suggest this nuclear T3 and/or T4 deficiency in the pituitary to be partially compensated. The observed increase in nuclear T4 and T3 receptor number in group1 might reflect a compensatory mechanism, which is probably evoked by the intracellular T3 deficiency in order to maintain cellular homeostasis. This observation bears on the relationship between nuclear T4 and I"3 receptors. The different binding characteristics between nuclear binding sites for T4 and T3 also observed in the present investigation suggest separate receptors for 1"4 and 1"3, although recent reports point to close relations between these sites [9] . It is, however, generally accepted that T4 is capable of exerting biological effects without conversion to T3 [13] . Thus, the increase in both T3 and T4 receptor number can be explained either by an immeasureable T4 deficiency or, what seems more probable, by a parallel increase in both T3 and T4 receptors, caused by thyroid hormone deficiency.
The normal T4 and T3 receptor number in cells from group 2, and the normal TRH test results, indicate that the cellular metabolic state is unaltered and is normal.
Alterations in intracellular thyroid hormone concentration and the intracellular transport mechanism can be excluded as the intracellular concentration of T4 or T3 after 90 min incubation did not differ significantly between the groups.
Taken together, our results indicate a difference in nuclear 3"4 and T3 binding in patients with Type 1 and Type2 diabetes. This difference probably reflects a compensated hypometabolic state in Type 1 diabetes related to a catabolic state, and may explain the clinical euthyroidism in group 1 in spite of their low serum T 3 levels.
